Drug Profile
Melanoma vaccine - Novavax/NCI
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator National Cancer Institute (USA); Novavax
- Class Cancer vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malignant melanoma
Most Recent Events
- 24 Jun 2005 Phase-I clinical trials in Malignant melanoma in USA (unspecified route)
- 09 Feb 2005 Preclinical trials in Malignant melanoma in USA (unspecified route)